Neurotoxicity of antiretroviral therapy

Charles T. Upton*, Babafemi O Taiwo, Kevin R. Robertson

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

The neurological outcome of HIV infection has changed dramatically in the era of HAART. Despite effective suppression of plasma viral load and a substantial decrease in the incidence of HIV-associated dementia, neurocognitive impairment and peripheral neuropathy remain widespread. The neurotoxic side effects of antiretroviral (ARV) agents are among several contributing factors to this continued prevalence. Effective penetration of the CNS by ARV agents is paramount to treating neurological symptoms as well as systemic infection, but may also exacerbate the severity of drug-related neurotoxicity. The neurotoxic side effects of ARV agents vary widely between and within drug classes. The risks and benefits of combination regimens continue to evolve as more effective treatment protocols are developed.

Original languageEnglish (US)
Pages (from-to)469-475
Number of pages7
JournalFuture Virology
Volume8
Issue number5
DOIs
StatePublished - May 1 2013

Keywords

  • CNS penetration effectiveness
  • HIV
  • HIV-associated neurocognitive disorders
  • antiretroviral therapy
  • inflammation
  • neurotoxicity
  • peripheral neuropathy

ASJC Scopus subject areas

  • Virology

Fingerprint Dive into the research topics of 'Neurotoxicity of antiretroviral therapy'. Together they form a unique fingerprint.

Cite this